| Thymopoiesis independent of common lymphoid progenitors D Allman, A Sambandam, S Kim, JP Miller, A Pagan, D Well, A Meraz, ... Nature immunology 4 (2), 168-174, 2003 | 730 | 2003 |
| Systematic review of case reports on the abscopal effect Y Abuodeh, P Venkat, S Kim Current problems in cancer 40 (1), 25-37, 2016 | 505 | 2016 |
| Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis R Morrison, SM Schleicher, Y Sun, KJ Niermann, S Kim, DE Spratt, ... Journal of oncology 2011, 2011 | 291 | 2011 |
| PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells VV Parekh, S Lalani, S Kim, R Halder, M Azuma, H Yagita, V Kumar, L Wu, ... The Journal of Immunology 182 (5), 2816-2826, 2009 | 243 | 2009 |
| Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial BC Creelan, C Wang, JK Teer, EM Toloza, J Yao, S Kim, AM Landin, ... Nature medicine 27 (8), 1410-1418, 2021 | 215 | 2021 |
| Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice L Wu, VV Parekh, CL Gabriel, DP Bracy, PA Marks-Shulman, RA Tamboli, ... Proceedings of the National Academy of Sciences 109 (19), E1143-E1152, 2012 | 199 | 2012 |
| The future of personalised radiotherapy for head and neck cancer JJ Caudell, JF Torres-Roca, RJ Gillies, H Enderling, S Kim, A Rishi, ... The Lancet Oncology 18 (5), e266-e273, 2017 | 190 | 2017 |
| The immune mechanisms of abscopal effect in radiation therapy GD Grass, N Krishna, S Kim Current problems in cancer 40 (1), 10-24, 2016 | 179 | 2016 |
| Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or … KA Ahmed, YA Abuodeh, MI Echevarria, JA Arrington, DG Stallworth, ... Annals of Oncology 27 (12), 2288-2294, 2016 | 138 | 2016 |
| Radiation therapy as a bridging strategy for CAR T cell therapy with axicabtagene ciloleucel in diffuse large B-cell lymphoma AJ Sim, MD Jain, NB Figura, JC Chavez, BD Shah, F Khimani, A Lazaryan, ... International Journal of Radiation Oncology* Biology* Physics 105 (5), 1012-1021, 2019 | 127 | 2019 |
| Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases KA Ahmed, S Kim, J Arrington, AO Naghavi, TJ Dilling, BC Creelan, ... Journal of neuro-oncology 133, 331-338, 2017 | 123 | 2017 |
| Radiation therapy is associated with improved outcomes in Merkel cell carcinoma T Strom, M Carr, JS Zager, A Naghavi, FO Smith, CW Cruse, JL Messina, ... Annals of surgical oncology 23, 3572-3578, 2016 | 96 | 2016 |
| Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice S Kim, S Lalani, VV Parekh, TL Vincent, L Wu, L Van Kaer The Journal of clinical investigation 118 (6), 2301-2315, 2008 | 87 | 2008 |
| Sirt2 inhibition enhances metabolic fitness and effector functions of tumor-reactive T cells I Hamaidi, L Zhang, N Kim, MH Wang, C Iclozan, B Fang, M Liu, ... Cell metabolism 32 (3), 420-436. e12, 2020 | 82 | 2020 |
| Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study S Sahebjam, PA Forsyth, ND Tran, JA Arrington, R Macaulay, AB Etame, ... Neuro-oncology 23 (4), 677-686, 2021 | 73 | 2021 |
| Harnessing the cell death pathway for targeted cancer treatment CK Speirs, M Hwang, S Kim, W Li, S Chang, V Varki, L Mitchell, ... American journal of cancer research 1 (1), 43, 2011 | 72 | 2011 |
| Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial S Kim, E Wuthrick, D Blakaj, Z Eroglu, C Verschraegen, R Thapa, M Mills, ... The Lancet 400 (10357), 1008-1019, 2022 | 55 | 2022 |
| Tumour radiosensitivity is associated with immune activation in solid tumours T Strom, LB Harrison, AR Giuliano, MJ Schell, SA Eschrich, A Berglund, ... European Journal of Cancer 84, 304-314, 2017 | 50 | 2017 |
| Improved local and regional control with radiotherapy for Merkel cell carcinoma of the head and neck T Strom, AO Naghavi, JL Messina, S Kim, JF Torres–Roca, J Russell, ... Head & neck 39 (1), 48-55, 2017 | 49 | 2017 |
| PTPN11 plays oncogenic roles and is a therapeutic target for BRAF wild-type melanomas KS Hill, ER Roberts, X Wang, E Marin, TD Park, S Son, Y Ren, B Fang, ... Molecular Cancer Research 17 (2), 583-593, 2019 | 46 | 2019 |
